These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
194 related articles for article (PubMed ID: 34355791)
21. Mucosal melanoma of the cranio-facial region: Surgical challenges and therapeutic options. Thierauf J; Glück AM; Plinkert P; Veit JA; Hoffmann TK; Körber A; Bergmann C Auris Nasus Larynx; 2019 Apr; 46(2):252-259. PubMed ID: 30082161 [TBL] [Abstract][Full Text] [Related]
22. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study. Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572 [TBL] [Abstract][Full Text] [Related]
23. Predictors of survival in head and neck mucosal melanoma. Schmidt MQ; David J; Yoshida EJ; Scher K; Mita A; Shiao SL; Ho AS; Zumsteg ZS Oral Oncol; 2017 Oct; 73():36-42. PubMed ID: 28939074 [TBL] [Abstract][Full Text] [Related]
24. Adjuvant chemotherapy and overall survival in adult medulloblastoma. Kann BH; Lester-Coll NH; Park HS; Yeboa DN; Kelly JR; Baehring JM; Becker KP; Yu JB; Bindra RS; Roberts KB Neuro Oncol; 2017 Feb; 19(2):259-269. PubMed ID: 27540083 [TBL] [Abstract][Full Text] [Related]
25. Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer. Haughey BH; Sinha P Laryngoscope; 2012 Sep; 122 Suppl 2():S13-33. PubMed ID: 22926949 [TBL] [Abstract][Full Text] [Related]
26. Optimal resection margin for head and neck cutaneous melanoma. Han AY; Dhanjani S; Pettijohn K; Patel PB; John MAS Laryngoscope; 2019 Jun; 129(6):1386-1394. PubMed ID: 30408184 [TBL] [Abstract][Full Text] [Related]
27. Comparison of Survival Outcomes With/Without Adjuvant Radiation Therapy in Desmoplastic Melanoma. Lewis GD; Guzman AK; Haque W; McLellan BN; Teh BS Dermatol Surg; 2021 Oct; 47(10):1333-1336. PubMed ID: 34537788 [TBL] [Abstract][Full Text] [Related]
28. Demographics and treatment trends in sinonasal mucosal melanoma. Gal TJ; Silver N; Huang B Laryngoscope; 2011 Sep; 121(9):2026-33. PubMed ID: 22024859 [TBL] [Abstract][Full Text] [Related]
29. Prognostic values of treatment modalities on head and neck mucosal melanomas in elderly patients: a population-based analysis. Chen E; Wu J; Liu Z; Yang S; Wu J; Ouyang P; Xie F Ann Transl Med; 2021 Mar; 9(5):391. PubMed ID: 33842612 [TBL] [Abstract][Full Text] [Related]
30. Adjuvant radiotherapy is not supported in patients with verrucous carcinoma of the oral cavity. Mohan S; Pai SI; Bhattacharyya N Laryngoscope; 2017 Jun; 127(6):1334-1338. PubMed ID: 28150306 [TBL] [Abstract][Full Text] [Related]
31. Impact of total radiotherapy dose on survival for head and neck Merkel cell carcinoma after resection. Patel SA; Qureshi MM; Mak KS; Sahni D; Giacalone NJ; Ezzat W; Jalisi S; Truong MT Head Neck; 2017 Jul; 39(7):1371-1377. PubMed ID: 28370725 [TBL] [Abstract][Full Text] [Related]
32. Real-World Outcomes of Inoperable and Metastatic Cutaneous Head and Neck Melanoma Patients. Rozendorn N; Shutan I; Feinmesser G; Grynberg S; Hodadov H; Alon E; Asher N Laryngoscope; 2024 Jun; 134(6):2762-2770. PubMed ID: 38230960 [TBL] [Abstract][Full Text] [Related]
33. Sinonasal mucosal melanoma: A 44-case study and literature analysis. Dréno M; Georges M; Espitalier F; Ferron C; Charnolé A; Dréno B; Malard O Eur Ann Otorhinolaryngol Head Neck Dis; 2017 Sep; 134(4):237-242. PubMed ID: 28442409 [TBL] [Abstract][Full Text] [Related]
35. Treatment modalities in sinonasal mucosal melanoma: A national cancer database analysis. Ganti A; Raman A; Shay A; Kuhar HN; Auger SR; Patel T; Kuan EC; Diaz AZ; Batra PS; Tajudeen BA Laryngoscope; 2020 Feb; 130(2):275-282. PubMed ID: 31021415 [TBL] [Abstract][Full Text] [Related]
36. Is sex an independent prognostic factor in cutaneous head and neck melanoma? Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966 [TBL] [Abstract][Full Text] [Related]
37. Clinical characterization and treatment of head and neck mucosal melanoma: a Chilean experience. Mimica X; Meneses M; Ferrer P; Caglevic C; Cohn D; Lavin M; Marin L; Contreras F Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Sep; 132(3):273-280. PubMed ID: 34088652 [TBL] [Abstract][Full Text] [Related]
38. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer. Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830 [TBL] [Abstract][Full Text] [Related]
39. Risk-based stratification in head and neck mucosal melanoma. Moya-Plana A; Mangin D; Dercle L; Taouachi R; Casiraghi O; Ammari S; Nguyen F; Temam S; Robert C; Gorphe P Oral Oncol; 2019 Oct; 97():44-49. PubMed ID: 31421470 [TBL] [Abstract][Full Text] [Related]
40. Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Brandwein-Gensler M; Teixeira MS; Lewis CM; Lee B; Rolnitzky L; Hille JJ; Genden E; Urken ML; Wang BY Am J Surg Pathol; 2005 Feb; 29(2):167-78. PubMed ID: 15644773 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]